Original Articles

Vol. 49 No. 1 (2025): Cerrahpaşa Medical Journal

Clinical Analysis of Multiple Primary Malignant Tumors: A Single-Center Experience

Main Article Content

Şahin Bedir
Nilay Şengül Samancı
Emir Çelik
Kerem Oruç
Ezgi Değerli
Sümeyra Derin
Gülin Alkan Şen
Nihan Şentürk Öztaş
Mustafa Özgüroğlu
Zeynep Hande Turna
Nebi Serkan Demirci
Fuat Hulusi Demirelli

Abstract

Objective: Multiple primary malignant tumors (MPMTs) are at least 2 separate malignancies that develop
independently. The incidence of patients diagnosed with MPMT is reported to be between 0.52% and
11.7% in various studies in different countries. The study aims to investigate the incidence, clinical features,
and survival of patients with MPMT.

Methods: About 121 patients diagnosed with MPMT in the institution were retrospectively analyzed between
January 2015 and December 2020. Multiple primary malignant tumors were defined as synchronous tumors
if they occurred within 6 months or less, and as metachronous tumors if they occurred more than 6 months.
All statistical analyses were performed using SPSS version 25.0.

Results: This study found the incidence of patients with MPMT was 2.6%. Two primary malignancies were
detected in 104 (85.9%) patients, 3 primary malignancies in 13 (10.7%), and 4 primary malignancies in 4
(3.3%). In this study, the most common tumor associations were found in patients with MPMT were lungcolorectal 12 (7.1%), lung-prostate 9 (5.3%), and prostate-bladder 9 (5.3%) tumors. Among the patients with
MPMT, 38 (31.4%) synchronous MPMT, 72 (59.5%) metachronous MPMT, and 11 (9%) both synchronous
and metachronous MPMT were found.

Conclusion: As a result, it was found that lung, colorectal, and prostate cancers were most common in
MPMT patients. This study showed that it is very important to distinguish between second primary, recurrence, or metastasis and that treatment methods can be applied to cure patients with the correct diagnosis.
Keywords: Colorectal cancer, lung cancer, metachronous tumors, multiple primary tumor, synchronous
tumors

Article Details